Some commonly used inducers of interferon such as viruses and double-stranded RNA are known to inhibit cellular protein synthesis. We have now shown that conventional inhibitors of macromolecular synthesis such as cycloheximide, 2-(4-methyl-2, 6-dinitroanilino)-N-methyl propionamide (MDMP) and i-fl-D-ribofuranosylbenzimidazole (DRB) can induce the production of significant amounts of interferon in human fibroblastoid cell lines. The interferon-inducing activity of these inhibitors depends on the concentration as well as the time of treatment with the inhibitors. These findings lead to the suggestion that the induction of human interferon may be mediated by a reduction in the critical concentration of a rapidly turning over repressor(s) which normally represses the interferon gene(s) in uninduced cells.
INTRODUCTION
The mechanism of interferon induction and the search for interferon inducers are two of the most thoroughly investigated areas in interferon research and have been extensively reviewed (Colby & Morgan, I97I; Merigan, I973; Ho & Armstrong, I975) . Generally, infective or inactivated RNA viruses and polyriboinosinic acid-polyribocytidylic acid complex [poly(rI) .poly(rC)] are two of the most potent and commonly used inducers of interferon. However, the mechanism by which these substances induce interferon remains unknown even though it has been suggested that the interferon structural gene(s) is 'derepressed' (Burke, I973) . Following induction, the amount of interferon produced in the induced cells is thought to be controlled by specific genetic regulatory element(s) (Tan et al. I97o; Vilcek & Ng, I97I ) . Evidence that these regulatory gene(s) exist is based on the observation that inhibitors of protein or RNA synthesis can enhance the production of interferon in cells induced by poly(rI).poly(rC) or by viruses. This effect, sometimes referred to as 'superinduction', has been compared with the 'superinduction' of tyrosine aminotransferase (TAT) in hepatoma cells treated with dexamethasone and actinomycin D (Tomkins et al. I966, 1972; Steinberg, Levinson & Tomkins, I975) . Consequently, the regulation of interferon has often been interpreted to be analogous to that of TAT. However, the regulation of the interferon system seems to differ in that (I) the interferon system is non-constitutive and (2) unlike TAT, which is an intracellular enzyme, interferon is rapidly released from cells (Tan, Jeng & Ho, 1972) , and so is not subjected to intracellular modulation of its turnover rate (Reel & Kenney, I968; Kenney et al. I973) .
In this paper, we present data suggesting that the induction of interferon in cultured cells 26-2 Y.H. TAN AND W. BERTHOLD is mediated through a mechanism involving a labile repressor protein(s). We show that it is possible to stimulate cultured ceils to produce interferon by treatment with inhibitors of RNA or protein synthesis alone.
METHODS
Cell cultures and induction of interferon. All cell cultures were grown in 75 cm2 plastic flasks (Microbiological Associates, Bethesda, Maryland) in minimal Eagle's medium (MEM) containing 4 mM-glutamine (G[BCO, Grand island, New York), 5o#g/ml of chlorotetracycline (GIBCO) and lO% foetal calf serum (Flow, Rockeville, Maryland) previously heat-inactivated at 6o°C for 9 ° min. This growth medium is referred to as regular medium. Diploid human skin fibroblasts were derived from skin explants from a normal female infant. Cell lines GM258, a trisomic 2I skin fibroblast, GM637 and GM638 were obtained from the Institute of Medical Research, Camden, New Jersey. Human WI-38 fibroblasts transformed by Simian virus 4 ° were cloned in Microtest II plates (Falcon, Columbia). The cell colonies representing clones in the wells of these dishes were directly induced with o'o5 ml sterile poly(rI).poly(rC) [20/zg/ml] for 2 h. The wells were washed three times with 0"25 ml of MEM and re-incubated overnight with 0.2 ml of regular medium. The interferon formed in each well was assayed with the aid of a home made replicator which transferred o.oi ml of medium from each well to the corresponding well of another Microtest Ii containing GM258 as assay cells. The procedure was repeated from the first assay plate to a second assay plate in order to dilute the interferon serially. The assay plates were challenged with vesicular stomatitis virus (VSV) at ro 6 p.f.u./well and examined under the microscope 24 h later for virus-induced c.p.e. In this manner, it was possible to identify those few cell clones (about 1%) which produced considerably more human interferon (i.e. amounts equivalent to 20o reference interferon units) than the other colonies. Cell line lO8 was derived from one of these colonies and grown in mass culture. Details of the procedure for replica cloning and replica induction of the clones will be reported elsewhere (Inoue, Tan & Tan, unpublished results) .
For the induction of interferon, cells were grown to confluent monolayers in 25 cm 2 plastic flasks. These were treated with 2 ml of regular medium containing poly(rI).poly(rC) and/or one of the inhibitors listed in the Tables. The inducing medium was removed at the indicated times and the cultures washed four times with MEM at 5 ml per wash. The cultures were re-incubated at 37 °C with 2 ml of regular medium for 8 h or the periods specified. Culture fluids were then harvested and centrifuged at IOO ooo g for 30 min before they were assayed for interferon.
For the superinduction of interferon formation, monolayer cultures of cells grown in 25 cm e flasks were treated with 2 ml of regular medium containing poly(rI).poly(rC) at 125/~g/ml and cycloheximide at 40/~g/ml for 7 h. Actinomycin D was added at 6"5 h at a final concentration of 5/~g/ml. At 7 h, the cultures were washed four times with MEM at 5 ml per wash and re-incubated with 2 ml of regular medium for a further 5 h at 37 °C.
Interferon assay. Culture fluid containing interferon was serially diluted in fourfold steps in regular medium, and o.2 ml of each dilution was added to confluent monolayers of trisomic 2r or disomic 2I human fibroblasts grown on Microtest H plates. The antiviral activity of interferon was measured as described by Tan (I975) and I unit is the amount of interferon required to inhibit the synthesis of 3H-uridine labelled VSV RNA by 50 %. The titration of the National Institutes of Health (NiH) reference leucocyte interferon preparation (G-o23-9oI-327) in our assay showed that I NIH reference interferon unit titred as Characterization of interferon activity. Preparations containing antiviral activity induced by poly(rI).poly(rC) or by cycloheximide in 2 ml of serum-free MEM were treated with the following enzymes (Sigma Chemicals): (i) bovine pancreatic trypsin at a final concentration of I mg/ml for I h at 37 °C. Tryptic activity was stopped by the addition of an equal amount of soya bean trypsin inhibitor. (ii) Bovine pancreatic ribonuclease A (proteinase free) at a final concentration of 5o #g/ml for z h in the presence or absence of I mM-EDTA at 37°C. (iii) Bovine pancreatic deoxyribonuclease I at a final concentration of 50 #g/ml for 2 h at 37°C. Antiviral preparations induced by poly(rI).poly(rC) or by cycloheximide were also dialysed against o.z N-HCI/KC1 buffer, pH 2, at 4 °C for 24 h and then neutralized to pH 7'0 to 7'8 by dialysis against MEM at 4 °C for 3 to 4 h.
After the treatment by enzymes or pH 2, antiviral activity was measured as above. The antiviral activity induced by inhibitors was also assayed on mouse L cells in the same manner as described above for human fibroblasts.
Protein and RNA synthesis. The incorporation of radioactive precursors into protein and RNA was performed under conditions identical to those used for the induction of interferon. Cells were seeded at 25 ooo cells/well in o. 15 ml of regular medium into a Microtest II plate. The cells were allowed to attach to the surface during an overnight incubation. The microplates were inverted to remove the medium and wiped dry with a piece of sterile gauze. Regular medium (oq ml) containing the drugs indicated in Fig. z and 3H -uridine or 3H-amino acids at the concentrations listed below were added to the wells. The cells were then incubated for further periods as specified in the experiments.
When the incorporation of radioactive precursors into cellular proteins and RNA after completion of treatment with the various inhibitors was measured (Fig. 3) , the medium containing the inhibitors or poly(rI).poly(rC) was removed at the end of the induction period. The plates were washed twice with MEM and o.I ml of regular medium containing aHuridine or 3H-amino acids at the concentration listed below was added to each well.
The incorporation of radioisotopes was stopped at the indicated time points (Fig. 2, 3 ) by addition of ~o #1 of a ~o % sodium dodecylsulphate (SDS: Biorad, Richmond, California) solution with o'r25 M-EDTA, pH 6, to each well. After at least 3o rain at 37°C the entire content of each well was transferred on to a filter disc 2"4 cm in diam., mounted at the end of a stainless steel pin. GF/C filters (Whatman) were used for the 3H-uridine labelling and Whatman 3 MM paper was used for the protein labelling. The filters were dried and soaked in ice cold Io% trichloroacetic acid (TCA) for 30 min. Those containing radioactive RNA were directly processed through two washes with 5 % TCA and two washes with 95 % ethanol, all in the cold. Those containing labelled protein were boiled in m°/o TCA for ~5 min, chilled and then processed as above. The dry filters were counted in 5 ml of toluenebased scintillation cocktail (o.6 % PPO, o.oo75 % POPOP obtained from Amersham/Searle).
Concentrations of active ingredients. 5,6-aH-uridine at I/zCi/ml (New England Nuclear, Boston, Mass.); a mixture of I 5 tritiated aminoacids at ~ #Ci/ml (Amersham/Searle, Arlington Heights, illinois); poly(rI).poly(rC) at r 25/zg/ml (P. L. Chemicals, Milwaukee, Wisconsin); cycloheximide at 40 #g/ml (Sigma Chemicals, St Louis, Missouri); MDMP(2-[4-methyl-2,6-dinitroanilino]-N-methyl propionamide) at Io -3 and ~o -4 M (Shell, kindly provided by Dr L. Gedamu); actinomycin D at 5 /~g/ml (Merck, Sharpe & Dohme, West Point, Pennsylvania); DRB (5,6-dichloro, I-fl-D-ribofuranosylbenzimidazole) at 13 #g/ml (Merck, Sharpe & Dohme). * Sets of duplicate cultures of line IO8 cells were treated with one of the above inhibitors or with poly(rI).-poly(rC) for the times indicated. At the end of these times, the cultures were washed four times with 5 ml of MEM and re-incubated with 2 ml of fresh regular medium for 8 h. The interferon titre is the mean produced in two cultures in 8 h after removal of the inhibitor concerned.
t Indicates the amount of interferon produced during the course of the treatment with cycloheximide, DRB or poly(rI).poly(rC).
:~ Only I/zg/ml cycloheximide.
The aneuploid human cell line lO8 (Tan, 1976) was examined for constitutive formation of interferon. In culture medium collected from confluent or even dense monolayers of lO8 cells, no antiviral activity could be detected even in a very sensitive assay system using human skin fibroblasts trisomic in chromosome 21 (Tan, I975) . The amounts of interferon induced in x o8 cells by inhibitors of macromolecular synthesis, such as cycloheximide, DRB, actinomycin D, and MDMP as well as by poly(rI).poly(rC) are shown in Table I and Fig. I . The effect on interferon production of varying the length of treatment with these inhibitors and with poly(rI).poly(rC) are shown in Table I . Concentrations of inhibitors were chosen so as to minimize cell lysis during the course of experiments, higher concentrations being noticeably cytotoxic. With the exception of actinomycin D, cultured lO8 cells produced more interferon with increased time of treatment by inhibitors or by poly(rI).poly(rC). In all cases there was no further increase beyond a particular time specific for each inhibitor. Only a small amount of interferon was induced when cells were exposed to actinomycin D for 1 h and none after exposure for 4 or more hours.
To determine whether the production of human interferon in response to these inhibitors required the synthesis of RNA and protein, the amounts of interferon produced during the periods of exposure to cycloheximide or DRB were measured (shown in parentheses in Table I ). Only a little interferon was produced in the presence of these drugs, but after their * Actinomycin D was added simultaneously with the inducers (+) and omitted in the controls (-). Culture fluids were harvested 4 h after the removal of the inducing agents from the cultures.
The titres of interferon represents the average of two titres obtained from duplicate plates of trisomic 2I skin fibroblasts. removal considerable amounts of interferon were measured (Table t and Fig. I ). Actinomycin D inhibited the induction of interferon induced by cycloheximide, DRB, MDMP and poly(rI).poly(rC) when added simultaneously with these agents (Table 2) . Thus, the induction of interferon apparently requires both newly synthesized protein and RNA. However, when actinomycin D was added after the cultures were treated with cycloheximide, or with both cycloheximide and poly(rl).poly(rC) for a sufficient period of time to induce interferon, an enhancement of interferon production was observed (Table 3) as has been reported previously (Tan et al. 197o; Vilcek, 197o) .
To ascertain that the antiviral activity measured in these tests was interferon the following tests were performed. Samples of interferon derived from poly(rI).poly(rC)-induced or cycloheximide-induced cell cultures were incubated with trypsin, ribonuclease (alone and with EDTA) and deoxyribonuclease at 37 °C and then assayed for activity. Trypsin destroyed the antiviral activity totally, whereas the other treatments did not (Table 4) o-7 0-7 256000 0-7 6"5 7 288000 0-7 6"5-7 12840 0-7 0-7 o 7 < i6 o-7 o-7 4-7 ~ 4o~ ooo o-7 0-7 6.5-7 812 7 ooo * Each titre represents the average from duplicate cultures of trisomic 2I skin fibroblasts. Culture fluids were harvested 5 h after the removal of the inducing agents. the antiviral activity derived from cultures treated with cycloheximide or with poly(rI).poly-(rC) survived treatment at pH 2 and 4 °C equally well and, like other human interferons, did not cross the species specificity barrier to protect mouse L cells against a VSV challenge. Both elicited a greater antiviral response in skin fibroblasts trisomic rather than disomic for chromosome 2I (Table I) ; this is in agreement with the suggestion that the action of human interferon is governed by gene(s) located on chromosome 2I (Tan, I975, I976) . Thus, the antiviral activity produced by Io8 cells in response to poly(rI).poly(rC) or cycloheximide has the characteristic properties of an interferon derived from human cells.
To determine whether the induction of interferon by inhibitors is an exclusive property of cell line Io8, a total of eight other human cell cultures were similarly treated with inhibitors. Of these, three were unrelated to cell line Io8 and five were subclones derived from cell line Io8. The results in Table 5 show that only two subclones of line Io8 could be readily induced by cycloheximide to produce interferon. These two subclones were also high producers of human interferon when induced with poly(rI).poly(rC), whereas the other lines tested produced considerably less. Cell line 638, when grown to an extremely high cell density, formed about I4 units of interferon in response to cycloheximide. t Grown to highly dense confluent monolayer cultures.
The effects of the interferon inducers on the incorporation of radioactive precursors into protein and RNA of confluent monolayers of line IO8 cells in wells of Microtest I[ plates were determined under the conditions found optimal for induction and production of interferon ( Fig. 2 and 3) . The incorporation of labelled amino acids into proteins during the induction period was strongly inhibited by cycloheximide and MDMP and minimally effected by poly(rl).poly(rC) and DRB. The incorporation of labelled uridine into RNA was inhibited by DRB, MDMP and partially by cycloheximide. Poly(rI).poly(rC) treatment resulted in a small but reproducible inhibition (Fig. 2) .
The reversibility of the inhibition of incorporation of labelled precursors after the exposure to the various drugs is shown in Fig. 3 . A partial recovery of protein synthesis was observed following the removal of cycloheximide, poly(rI).poly(rC) with cycloheximide, or poly(rI). poly(rC) with cycloheximide and actinomycin D. Recovery of protein synthesis was nearly complete in cells after the removal of MDMP. The labelling of RNA resumed to nearly control levels after DRB, MDMP and poly(rl).poly(rC) removal and only partially after cycloheximide treatment. RNA synthesis was completely blocked when cells had been exposed to a specific sequence of treatment with poly(rI).poly(rC), cycloheximide and actinomycin D. 
DISCUSSION
A helical double-stranded structure of polyribonucleotides is thought to be required for the induction of interferon synthesis in cell cultures (Field et al. 1967; Colby & Chamberlin, ~969) , though in the studies of Baron et al. (I969) , single stranded polynucleotides also induced interferon formation. Other substances such as phytohaemagglutinin, endotoxin and tilorone, which are chemically quite different from the double-stranded polyribonucleotides and RNA viruses, are also known to induce interferon production in certain cell types. In one report, treatment of mice with cycloheximide resulted in formation of interferon (Youngner, Stinebring & Taube, ~965), but it is not clear if this was related to the release of endotoxin by cycloheximide in the mouse. Indeed, no bacteraemia and no endotoxin could be detected in serum from cycloheximide-treated mice (J. S. Youngner, personal communication). Thus the induction of mouse interferon in the intact mouse by cycloheximide may be explained by a mechanism similar to that described here. It is clear that no common specific chemical structure that confers interferon-inducing activity can readily be assigned to different kinds of inducers. Therefore, we set out to search for a common biological effect (Colby, I97I) do not affect the initiation of protein synthesis by the same mechanism as double-stranded RNAs (Hunter et al. 1975) . We therefore tested the ability of known inhibitors of cellular RNA and protein synthesis to induce interferon in cultured cells. In our present study all reversible inhibitors of cellular protein and RNA synthesis induced interferon in those cell cultures that produce large amounts of interferon in response to poly(rI).poly(rC) (Fig. I, Table 5 ), but not in cultures which responded less well to poly(rI).poly(rC). This may simply be a question of the threshold of sensitivity of the assay for interferon activity, because the amounts of interferon induced by inhibitors are lower than the amount induced by poly(rI). normal cultures were not inducible by cycloheximide, were grown to extremely high cell density and then treated with cycloheximide. Small but detectable concentrations of interferon were then released. Thus, the induction of human interferon by inhibitors of macromolecular synthesis is not an exclusive property of line lO8 and some of its subclones. Alternatively, the inducibility by metabolic inhibitors may reflect the degree to which the interferon gene(s) is maintained in the non-transcriptive state. Cells which are strongly maintained in this state would respond poorly to inducers whereas cells which are weakly repressed should be easily inducible with inhibitors of macromolecular synthesis as well as with poly(rI).poly(rC). The concentration of cycloheximide used to induce interferon was shown to inhibit cellular synthesis of protein and to a lesser extent of RNA (Fig. 2) . More importantly, the production of interferon occurred only after the removal of cycloheximide. DRB is also shown to reversibly inhibit the synthesis of RNA and to a lesser extent of protein ( Fig. 2 and  3 )-We presume that the inhibitory effects of these substances on macromolecular synthesis are related to their interferon-inducing activity. Actinomycin D treatment for ~ h induced a small amount of interferon, presumably related to the inhibition of about 6o ~o of RNA synthesis in the treated cells. However, as expected, extending the time of exposure to actinomycin D led to no detectable levels of interferon, because there was a cumulative inhibition of RNA synthesis of more than 95 ~o. At this level of inhibition one would expect the transcription of most de novo RNAs including interferon mRNA, to be inhibited as well.
In summary, we suggest that the inhibitory activity of the various substances tested is associated with their capacity to induce interferon. The current consensus of opinion concerning the mechanism of interferon induction is that it involves a derepression of the interferon gene(s). The present finding that inhibitors of RNA and protein synthesis are capable of inducing interferon production suggests that the proposed repressor substance which normally inhibits the transcription of the interferon gene is a rapidly turning over protein. Any substance inhibiting the overall synthesis of cellular RNA or protein could reduce the concentration of such a labile repressor and allow the transcription of the interferon gene. A scheme of the proposed mechanism for the induction of interferon is given in Fig. 4 .
